INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.००
arrow_upward
+०.४६%(+०.००४६) 1D
अक्टोबर २०, ०९:४६:४५ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.०१
High
US$ १.०१
Low
US$ ०.९९
Mkt. cap
१०.३९ करोड
Avg. vol.
२८.४५ लाख
Volume
१.०४ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.०१
High
US$ १.०१
Low
US$ ०.९९
Mkt. cap
१०.३९ करोड
Avg. vol.
२८.४५ लाख
Volume
१.०४ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
Morningstar
·
४७ मिनेट पहिले
Trex Company to Ring NYSE Opening Bell in Celebration of 30th Anniversary
CNBC
·
५५ मिनेट पहिले
Investors look to earnings to reset the bull market. The key level to watch on the S&P 500
Stock Titan
·
१ घण्टा पहिले
Primech Holdings (Nasdaq: PMEC) Announces Primech AI’s HYTRON Exhibition at CLEAN KOREA 2026 with Exclusive South Korean Distributor NCM
Reuters
·
३९ मिनेट पहिले
Wall St set for lower open as oil prices jump, earnings in focus
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc